158 related articles for article (PubMed ID: 3286112)
1. Clinical experience with gossypol in non-Chinese men: a follow-up.
Coutinho EM; Melo JF
Contraception; 1988 Feb; 37(2):137-51. PubMed ID: 3286112
[TBL] [Abstract][Full Text] [Related]
2. Antispermatogenic action of gossypol in men.
Coutinho EM; Melo JF; Barbosa I; Segal SJ
Fertil Steril; 1984 Sep; 42(3):424-30. PubMed ID: 6468676
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hormone profiles and the restoration of spermatogenesis in men treated with gossypol.
Gu ZP; Wang YX; Sang GW; Wang WC; Chen ZX; Zhao XJ; Shao QX; Jiang Y
Int J Androl; 1990 Aug; 13(4):253-7. PubMed ID: 2117586
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of men in the recovery period immediately after the cessation of gossypol treatment.
Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
Contraception; 1988 Feb; 37(2):119-28. PubMed ID: 3131064
[TBL] [Abstract][Full Text] [Related]
5. Clinical microdose study of gossypol: effect on sperm motility and renal function.
Frick J; Aulitzky W; Kalla NR
Contraception; 1988 Feb; 37(2):153-62. PubMed ID: 3370988
[TBL] [Abstract][Full Text] [Related]
6. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
7. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
Soufir JC; Jouannet P; Marson J; Soumah A
Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
[TBL] [Abstract][Full Text] [Related]
8. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study.
Coutinho EM; Athayde C; Atta G; Gu ZP; Chen ZW; Sang GW; Emuveyan E; Adekunle AO; Mati J; Otubu J; Reidenberg MM; Segal SJ
Contraception; 2000 Jan; 61(1):61-7. PubMed ID: 10745071
[TBL] [Abstract][Full Text] [Related]
9. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
10. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
[TBL] [Abstract][Full Text] [Related]
11. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
12. Gossypol as oral contraceptive for male: trial case report.
Hoshiai H; Uehara S; Mori R; Nagaike F; Tsuiki A; Suzuki M
Tohoku J Exp Med; 1982 Nov; 138(3):275-80. PubMed ID: 6818716
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
14. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
15. Recovery of sperm production following the cessation of gossypol treatment: a two-centre study in China.
Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
Int J Androl; 1988 Feb; 11(1):1-11. PubMed ID: 3356480
[TBL] [Abstract][Full Text] [Related]
16. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
Knuth UA; Yeung CH; Nieschlag E
Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
[TBL] [Abstract][Full Text] [Related]
17. Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation.
Bastias MC; Kamijo H; Pavlou SN
Fertil Steril; 1993 Jun; 59(6):1261-5. PubMed ID: 8495775
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of gossypol on human sperm motility: relationship with time, temperature and concentration.
Hong CY; Huang JJ; Wu P
Hum Toxicol; 1989 Jan; 8(1):49-51. PubMed ID: 2714811
[TBL] [Abstract][Full Text] [Related]
19. Further observations on the role of varicocele in human male infertility.
Macleod J
Fertil Steril; 1969; 20(4):545-63. PubMed ID: 5795037
[TBL] [Abstract][Full Text] [Related]
20. Influence of testosterone substitution on sperm suppression by LHRH agonists.
Bouchard P; Garcia E
Horm Res; 1987; 28(2-4):175-80. PubMed ID: 2969861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
